ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 994

Increased Antibody and T-cell Responses Following Treatment of Collagen-Induced Arthritis in C57Bl/6 Mice with Organic Dust Inhalants

Michael Duryee1, Jill Poole 1, Amy Nelson 1, Katherine Janike 1, Kathryn Rentfro 1, Lynell Klassen 1, James O'Dell 2, Bryant England 3, Geoffrey Thiele 2 and Ted Mikuls 2, 1University of Nebraska Medical Center, Omaha, NE, 2VA Nebraska-Western IA Health Care System & University of Nebraska Medical Center, Omaha, NE, 3VA Nebraska-Western IA Health Care System & University of Nebraska Medical Center, Omaha

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: Animal models, anti-citrullinated protein/peptide antibodies (ACPA), antibody, T cells and rheumatoid arthritis, Type II collagen

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 11, 2019

Title: RA – Animal Models Poster

Session Type: Poster Session (Monday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Increasing evidence suggests that inhalant exposures, such as tobacco smoke or silica, are implicated in the initiation of autoimmunity leading to rheumatoid arthritis (RA). To further study the relationship between inhalant lung injury and RA-related autoimmunity, a mouse model of collagen induced arthritis was subjected to inhalation of organic dust extract (ODE) and disease-specific autoantibody and T cell responses were measured.

Methods: Male C57BL/6 mice were injected with chicken collagen type II plus Freund’s complete adjuvant (CIA) or saline on day 1 and 21.  ODE or saline was instilled by intranasal inhalation daily for 5 weeks. Groups are identified as: 1) Sham (saline injection + saline inhalation), 2) ODE, 3) CIA, and 4) ODE + CIA.  At 5 weeks, IgG antibody to malondialdehyde-acetaldehyde (MAA) and anti-citrullinated protein antibody (ACPA) were measured in serum. T-cell proliferation assays were performed by IFN-γ ELISPOT using human serum albumin (HSA) that was either MAA modified or citrullinated (CIT) as the stimulating antigen. 

Results: Serum IgG anti-MAA antibody concentrations were significantly increased (p< 0.0001) in ODE + CIA mice compared to all other groups Figure (A).  In contrast, ACPA concentrations were significantly lower (p< 0.0001) in CIA + ODE mice compared to CIA alone with the former group demonstrating autoantibody concentrations similar to sham and ODE mice (B).  T-cell proliferations against HSA-MAA were significantly increased in both CIA (p< 0.0001) and CIA + ODE (p< 0.01) mice compared to sham and ODE, yet neither of these differed significantly from each other (C). In contrast, T cell proliferations  were significantly decreased (p< 0.01) in the CIA + ODE group compared to CIA alone when HSA-CIT was used as the stimulating antigen (D).

Conclusion: Increased anti-MAA antibody and decreased ACPA concentrations in the ODE + CIA treated group compared to CIA alone suggests a shift in autoimmune response when arthritis prone mice are exposed to inhalant injury.  Although mechanisms underpinning these “shifts” require further investigation, an increase in proliferating T-cells to MAA and a simultaneous decrease to citrullinated antigen suggests that inhalant injury may reduce immune responses to disease-specific antigen (citrullinated antigen) at the expense of enhanced responses to a more ubiquitous autoantigen (MAA-modified antigen).  This novel animal model that incorporates CIA and inhalant injury, has the potential of providing much needed insight into the complex interplay between mucosal injury and autoimmunity that characterizes RA.

Figure 1. Increased Antibody and T-cells Response to MAA Modified Antigens in C57bl/6 Treated with Sham, CIA, ODE, or ODE+CIA. -A- Serum anti-MAA antibody -CIA p<0.05 vs. sham or ODE; CIA+ODE p<0.0001 vs. all other groups-. -B- Serum ACPA -CIA p<0.0001 vs. all other groups; p=NS for all other comparisons-. -C- T-cell proliferation to HSA-MAA -CIA p<0.0001 vs. sham or ODE; CIA+ODE p<0.01 vs. sham or ODE; p=NS for CIA vs. CIA+ODE-. -D- T-cell proliferation to HSA-CIT -CIA p<0.01 vs. all other groups-. N=10 mice per group.


Disclosure: M. Duryee, None; J. Poole, None; A. Nelson, None; K. Janike, None; K. Rentfro, None; L. Klassen, None; J. O'Dell, None; B. England, None; G. Thiele, None; T. Mikuls, BMS, 2, Horizon, 2.

To cite this abstract in AMA style:

Duryee M, Poole J, Nelson A, Janike K, Rentfro K, Klassen L, O'Dell J, England B, Thiele G, Mikuls T. Increased Antibody and T-cell Responses Following Treatment of Collagen-Induced Arthritis in C57Bl/6 Mice with Organic Dust Inhalants [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/increased-antibody-and-t-cell-responses-following-treatment-of-collagen-induced-arthritis-in-c57bl-6-mice-with-organic-dust-inhalants/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/increased-antibody-and-t-cell-responses-following-treatment-of-collagen-induced-arthritis-in-c57bl-6-mice-with-organic-dust-inhalants/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology